Maravai LifeSciences Holdings, Inc. (MRVI)

MRVI Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,146	1,646	3,652	10,798	7,232	-
Market Cap Growth	-37.99%	-54.93%	-66.18%	49.29%	-	-
Enterprise Value	1,142	1,628	3,547	10,777	7,587	366
PE Ratio	-	-13.83	16.59	59.32	81.29	-
PS Ratio	4.19	5.70	4.14	13.51	25.46	-
PB Ratio	2.79	3.95	6.70	34.22	81.71	-
P/FCF Ratio	-89.88	22.38	7.21	30.48	44.84	-
P/OCF Ratio	35.11	13.04	6.81	29.30	47.52	-
EV/Sales Ratio	4.17	5.63	4.02	13.48	26.71	2.55
EV/EBITDA Ratio	1.57	2.22	10.45	35.06	51.12	7.47
EV/EBIT Ratio	1.70	2.38	11.77	39.36	61.89	14.72
EV/FCF Ratio	-89.64	22.13	7.00	30.42	47.04	52.46
Debt / Equity Ratio	1.35	1.34	0.97	1.68	6.67	2.76
Debt / EBITDA Ratio	0.77	0.76	1.55	1.73	3.98	7.98
Debt / FCF Ratio	-22.92	7.57	1.04	1.50	3.66	56.01
Quick Ratio	10.14	7.20	7.00	7.13	2.20	1.45
Current Ratio	11.32	8.00	7.70	7.89	2.54	2.05
Asset Turnover	0.15	0.14	0.40	0.47	0.31	0.26
Interest Coverage	14.99	14.88	14.77	9.05	3.99	0.83
Return on Equity (ROE)	-28.10%	-24.10%	46.70%	78.70%	77.40%	-3.10%
Return on Assets (ROA)	-7.00%	-5.70%	10.10%	10.80%	9.60%	-0.80%
Return on Capital (ROIC)	1.22%	0.67%	41.38%	49.00%	17.10%	4.57%
Earnings Yield	-11.42%	-7.23%	6.03%	1.69%	1.23%	-
FCF Yield	-2.11%	4.47%	13.87%	3.28%	2.23%	-
Buyback Yield / Dilution	-0.45%	48.33%	0.96%	-791.81%	88.62%	-0.00%
Total Shareholder Return	-0.45%	48.33%	0.96%	-791.81%	88.62%	-0.00%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).